Ex Parte SULLIVAN - Page 12




            Appeal No. 2003-0540                                                        Page 12               
            Application No. 09/737,001                                                                        


            claimed Shore D hardness limitations as set forth in independent claims 9 and 10.  In             
            that regard, we note that a disclosure that merely renders the later-claimed invention            
            obvious is not sufficient to meet the written description requirement; the disclosure must        
            describe the claimed invention with all its limitations.  See Tronzo v. Biomet Inc., 156          
            F.3d 1154, 1158-60, 47 USPQ2d 1829, 1832-34 (Fed. Cir. 1998); Lockwood v.                         
            American Airlines, Inc., 107 F.3d 1565, 1571-72, 41 USPQ2d 1961, 1966 (Fed. Cir.                  
            1997); Vas-Cath Inc., 935 F.2d at 1563-64, 19 USPQ2d at 1117; In re Winkhaus, 527                 
            F.2d 637, 640, 188 USPQ 129, 131 (CCPA 1975); In re DiLeone, 436 F.2d 1404, 1405,                 
            168 USPQ 592, 593 (CCPA 1971); In re Wohnsiedler, 315 F.2d 934, 937, 137 USPQ                     
            336, 339 (CCPA 1963).                                                                             


                   For the reasons set forth above, the decision of the examiner to reject claims 9           
            and 10, and claims 11 to 13 dependent thereon, under 35 U.S.C. § 112, first paragraph,            
            is affirmed.                                                                                      


                                       ADDITIONAL CONSIDERATION                                               
                   In any further prosecution before the examiner, we recommend that the                      
            examiner determine if claims 9 to 13 are patentable over U.S. Patent No. 4,431,193 to             
            Nesbitt alone or in combination with other prior art.  Any rejection of claims 9 to 13 on         
            prior art requires the Group Director's approval (see MPEP § 2307.02) since these                 








Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007